Takara Bio Europe Launches Shasta™ Single-Cell System, Advancing High-Throughput Oncology Biomarker Discovery

Takara Bio Europe, a wholly owned subsidiary of Takara Bio Inc., announces the launch of the Shasta™ Single-Cell System at the 2024 Human Cell A...

September 27, 2024 | Friday | News
QIAGEN Launches PAXgene Urine Liquid Biopsy Set, Advancing Non-Invasive cfDNA Collection and Stabilization

PAXgene Urine Liquid Biopsy Set with collection cup and a nucleic acid stabilizing tube enables non-invasive sample collection and direct cell-free DNA sta...

September 26, 2024 | Thursday | News
Roche Announces Positive Phase III Results for Gazyva/Gazyvaro in Lupus Nephritis, Demonstrating Superiority Over Standard Therapy Alone

Roche announced positive topline results from the Phase III REGENCY study, which evaluated Gazyva®/Gazyvaro® (obinutuzumab) in people with active...

September 26, 2024 | Thursday | News
Ascend Strengthens Global Gene Therapy Support with New Multi-Million Dollar Investments in Technology and Flexible Capacity

Continued Investment in Technology & Flexible Capacity, Including New Fill/Finish Capabilities, Fortify the Global Gene Therapy Support Offer at Ascend...

September 25, 2024 | Wednesday | News
Agarose Bead Technologies Completes Major Expansion of Spanish Facility to Meet Global Demand for Pharmaceutical Resins

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins, proudly announces the completion of a major expansion at its faci...

September 25, 2024 | Wednesday | News
Metabolomics Diagnostics Develops PrePsia, an Innovative Test to Predict Preeclampsia Risk in Early Pregnancy

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict t...

September 25, 2024 | Wednesday | News
European Commission Approves Junshi Biosciences' Toripalimab for Two Key Cancer Indications

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

September 25, 2024 | Wednesday | News
Genespire Secures €46.6M Series B to Propel First Pediatric Gene Therapy into Clinical Trials

Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic One of the la...

September 25, 2024 | Wednesday | News
Roche Launches cobas® Respiratory flex Test, Powered by Innovative TAGS Technology

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets to be detected simultaneously in a single patient sample on t...

September 24, 2024 | Tuesday | News
Oxford-Harrington Rare Disease Centre Kicks Off Bi-Annual Symposium at University of Oxford

The Oxford-Harrington Rare Disease Centre (‘OHC’), a partnership between the University of Oxford, UK and Harrington Discovery Institute at U...

September 24, 2024 | Tuesday | News
QIAGEN Partners with Bode Technology to Expand Global Use of GEDmatch PRO in Forensic Investigations

QIAGEN chooses Bode Technology as its exclusive global commercial partner to accelerate use of GEDmatch PRO genealogy database in law enforcement and i...

September 24, 2024 | Tuesday | News
VERDOT® to Build New 4,200 Square-Meter Headquarters and Manufacturing Facility in Riom, France

4200 square-meter headquarter and manufacturing facility in Riom, France Consolidation of existing facilities with 150% additional manufacturing capacit...

September 23, 2024 | Monday | News
ESMO 2024 Congress: Breakthroughs in Cancer Treatment and Key Approvals

The European Society for Medical Oncology (ESMO) 2024 Congress, held from September 13 to 17 in Barcelona, brought together global oncology experts to un...

September 23, 2024 | Monday | News
EMA's CHMP Recommends Approval of Intas Pharmaceuticals' HETRONIFLY® (Serplulimab) for Extensive-Stage Small Cell Lung Cancer

Intas Pharmaceuticals announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive op...

September 23, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close